OR30-02 Efficacy and Safety Comparison Between U100 Regular Human Insulin and U100 Rapid Acting Insulin When Delivered by a 24 Hour Wearable Insulin Delivery Device in Type 2 Diabetes
Mora, Pablo, Sutton, David R, Gore, Ashwini, Baliga, Bantwal S, Goldfaden, PharmD, Rebecca, Nikkel, Carla, Sink II, John, Adams-Huet, Beverley
Published in Journal of the Endocrine Society (08.05.2020)
Published in Journal of the Endocrine Society (08.05.2020)
Get full text
Journal Article